- Home
- ZLAB vs HBI Comparison
ZLAB vs HBI Comparison
Compare ZLAB & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- HBI
- Stock Information
- Founded
- ZLAB 2013
- HBI 1901
- Country
- ZLAB China
- HBI United States
- Employees
- ZLAB N/A
- HBI N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- HBI Clothing/Shoe/Accessory Stores
- Sector
- ZLAB Health Care
- HBI Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- HBI Nasdaq
- Market Cap
- ZLAB 3.4B
- HBI 2.2B
- IPO Year
- ZLAB 2017
- HBI 2006
- Fundamental
- Price
- ZLAB $33.00
- HBI $6.29
- Analyst Decision
- ZLAB Buy
- HBI Buy
- Analyst Count
- ZLAB 6
- HBI 4
- Target Price
- ZLAB $57.22
- HBI $6.50
- AVG Volume (30 Days)
- ZLAB 827.1K
- HBI 5.3M
- Earning Date
- ZLAB 11-11-2025
- HBI 11-06-2025
- Dividend Yield
- ZLAB N/A
- HBI N/A
- EPS Growth
- ZLAB N/A
- HBI N/A
- EPS
- ZLAB N/A
- HBI 0.25
- Revenue
- ZLAB $427,799,000.00
- HBI $3,540,309,000.00
- Revenue This Year
- ZLAB $41.60
- HBI $1.61
- Revenue Next Year
- ZLAB $53.42
- HBI N/A
- P/E Ratio
- ZLAB N/A
- HBI $24.93
- Revenue Growth
- ZLAB 32.56
- HBI 2.95
- 52 Week Low
- ZLAB $20.17
- HBI $3.96
- 52 Week High
- ZLAB $44.34
- HBI $9.10
- Technical
- Relative Strength Index (RSI)
- ZLAB 50.01
- HBI 58.83
- Support Level
- ZLAB $31.68
- HBI $6.23
- Resistance Level
- ZLAB $33.06
- HBI $6.40
- Average True Range (ATR)
- ZLAB 1.33
- HBI 0.14
- MACD
- ZLAB 0.28
- HBI -0.07
- Stochastic Oscillator
- ZLAB 86.72
- HBI 57.69
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated, as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina. Hanesbrands has agreed to be acquired by Canadian rival Gildan.